ID: ALA1208993

Max Phase: Preclinical

Molecular Formula: C19H17NO2

Molecular Weight: 291.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCc1ccc(OC(=O)c2ccc3ccccc3c2)cc1

Standard InChI:  InChI=1S/C19H17NO2/c20-12-11-14-5-9-18(10-6-14)22-19(21)17-8-7-15-3-1-2-4-16(15)13-17/h1-10,13H,11-12,20H2

Standard InChI Key:  FGLUDCJXOKUDPK-UHFFFAOYSA-N

Associated Targets(Human)

Dynamin-1 215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.35Molecular Weight (Monoisotopic): 291.1259AlogP: 3.56#Rotatable Bonds: 4
Polar Surface Area: 52.32Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 4.04CX LogD: 1.73
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.59Np Likeness Score: -0.23

References

1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S..  (2010)  Synthesis of potent chemical inhibitors of dynamin GTPase.,  20  (16): [PMID:20621477] [10.1016/j.bmcl.2010.06.092]

Source